First half year 2017 report and presentation
Oslo, 29 August 2017 – Please find enclosed the financial report and presentation for second quarter and first half year 2017. PCI Biotech Q2 2017 Report PCI Biotech Q2 2017 Presentation PCI Biotech reported important progress for the fimaCHEM programme during 1H 2017, with early promising signs of effect in Phase I. The study has […]
PCI Biotech appoints Dr Hans Olivecrona as Chief Medical Officer
Oslo (Norway), 23 August 2017 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company is pleased to announce the appointment of Dr. Hans Olivecrona MD PhD as Chief Medical Officer (CMO). Dr Olivecrona will also serve as a member of PCI Biotech’s executive management team. He will lead the execution of all clinical development […]
Invitation to first half year 2017 presentation
Oslo, 21 August 2017 – PCI Biotech invites to a presentation of the company’s second quarter and first half year 2017 report on Tuesday 29 August 2017 at Oslo Cancer Cluster Innovation Park. Time: Tuesday August 29, 09am – 10am CEST (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation […]